Results 101 to 110 of about 22,257 (214)

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. [PDF]

, 2017
Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA).
Adrian Ciurea, Almut Scherer, Burkhard Möller, Giorgio Tamborrini, Jürg Bernhard, Lukas M. Wildi, Michael J. Nissen, Monika Hebeisen, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program, Pascal Zufferey, Pascale Exer, Raphael Micheroli   +11 more
core   +5 more sources

Rehabilitation Referral in Rheumatology: Insights From the RISE Registry

ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objective The aim was to describe the percentage of patients with axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) in the Rheumatology Informatics System for Effectiveness (RISE) Registry who received a rehabilitation referral.
Astia Allenzara, Jing Li, Gabriela Schmajuk, Samannaaz S. Khoja, Louise M. Thoma   +4 more
wiley   +1 more source

A Review of Ankylosing Spondylitis [PDF]

, 2017
Ankylosing spondylitis (AS) is a systemic autoimmune disorder that induces ankylosis of the spine (fusion of the vertebrae at their various joints) and inflammatory arthritis of peripheral joints among other symptoms.
Owen, Hannah L
core   +1 more source

Bimekizumab plus topical photochemotherapy effective in palmoplantar pustulosis in a patient with hidradenitis suppurativa

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Neda Cramer, Johannes Mohr, Michael P. Schön, Rotraut Mössner   +3 more
wiley   +1 more source

Rehabilitation Interventions Delivered via Telehealth to Support Self‐Management of Rheumatic and Musculoskeletal Disease: A Scoping Review

Arthritis &Rheumatology, Volume 78, Issue 1, Page 26-36, January 2026.
Objective To identify and summarize existing telerehabilitation interventions for people living with rheumatic and musculoskeletal diseases (RMDs), including the rehabilitation components, the technology used, the type of health care professional (HCP) interaction, and how the effectiveness is evaluated.
Thomas A. Ingram, Rosemarie Barnett, Nuzhat Shakaib, Simon Jones, Raj Sengupta, Peter C. Rouse   +5 more
wiley   +1 more source

Late‐Onset Spondyloarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin ‐17 Blockade May Have a Therapeutic Role

Arthritis &Rheumatology, Volume 78, Issue 1, Page 131-140, January 2026.
Objective Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder/hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvement in both PMR and spondyloarthritis (SpA), with sacroiliac joint and perientheseal spinal bone marrow edema (BME) being characteristic of SpA ...
Kerem Abacar, Gabriele De Marco, Jake Weddell, Katya Meridor, Tom Macleod, Andrew Scarsbrook, Kulveer Mankia, Edward Vital, Andrew Barr, Colin Pease, Helena Marzo‐Ortega, Sarah L. Mackie, Dennis McGonagle   +12 more
wiley   +1 more source

Current Challenges in Managing SpA

Journal of Clinical Rheumatology and Immunology
Managing spondyloarthritis (SpA) presents several complex challenges that impact patient outcomes. One of the foremost issues is the delay in diagnosis, often due to overlapping symptoms with other conditions and insufficient awareness among clinicians ...
Georg Schett
doaj   +1 more source

Study protocol: Comparison of the effect of treatment with Nonsteroidal anti- inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti- tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial [PDF]

, 2017
Introduction There is some evidence that non-steroidal anti-inflammatory drugs (NSAIDs), in particular celecoxib, might possess not only a symptomatic efficacy but also disease-modifying properties in ankylosing spondylitis (AS), retarding the ...
Listing, Joachim, Muche, Burkhard, Poddubnyy, Denis, Proft, Fabian, Rios-Rodriguez, Valeria, Sieper, Joachim   +5 more
core   +1 more source

Overexpression of the IL‐23/IL‐17A Axis and Their Receptors (IL‐23R and IL‐17RA) in Gingival Tissue of Patients With Periodontitis

International Journal of Dentistry, Volume 2026, Issue 1, 2026.
Background Periodontitis is a chronic immunoinflammatory disease involving various components that affect the tissues surrounding the tooth. The host immune response to the presence of periodontopathogenic microorganisms activates several cytokine systems involved in alveolar bone resorption in periodontitis; among them is the receptor activator of ...
Sonia I. Vázquez-Jiménez, Ruth Rodríguez-Montaño, Vianeth M. Martínez-Rodríguez, Juan M. Guzmán-Flores, Ana L. Zamora-Perez, Susana del Toro Arreola, Celia Guerrero-Velázquez, Hua-Hong Chien   +7 more
wiley   +1 more source

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis

RMD Open, 2019
Objective Spondyloarthritis (SpA) can encompass axial, peripheral and extra-articular disease manifestations. Patients are classified as axial or peripheral SpA depending on the presence or absence of current back pain, independently of the other disease
Janneke J de Winter, Jacqueline E Paramarta, Henriëtte M de Jong, Marleen G van de Sande, Dominique L Baeten   +4 more
doaj   +1 more source